Previous Close | 5.36 |
Open | 5.34 |
Bid | 5.19 x 2200 |
Ask | 5.37 x 3100 |
Day's Range | 5.29 - 5.39 |
52 Week Range | 4.30 - 6.91 |
Volume | |
Avg. Volume | 915,596 |
Market Cap | 6.938B |
Beta (5Y Monthly) | 0.58 |
PE Ratio (TTM) | 10.76 |
EPS (TTM) | 0.50 |
Earnings Date | N/A |
Forward Dividend & Yield | 0.19 (3.57%) |
Ex-Dividend Date | Mar 14, 2024 |
1y Target Est | 5.31 |
Subscribe to Yahoo Finance Plus to view Fair Value for ICL
TEL AVIV, Israel, March 14, 2024--ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today announced the filing of its annual report on Form 20-F for the fiscal year ended December 31, 2023, with the U.S. Securities and Exchange Commission (SEC). Included, for the third year in a row, are Task Force on Climate-related Financial Disclosures (TCFD), which provide information on what ICL is doing to mitigate the risks of climate change and reduce its carbon footprint.
TEL AVIV, Israel, February 28, 2024--ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today announced it has acquired Nitro 1000, a manufacturer, developer and provider of biologicals in Brazil for approximately $30 million. This acquisition marks another meaningful step into the biologicals market, while expanding ICL’s product offerings and positioning the company for further expansions into new and adjacent end-markets.
TEL AVIV, Israel, February 28, 2024--ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today reported its financial results for the fourth quarter and full year ended December 31, 2023. Consolidated annual sales were $7,536 million versus a record $10,015 million in 2022. Net income was $647 million versus $2,159 million, while adjusted net income was $715 million versus $2,350 million. Annual adjusted EBITDA was $1,754 million versus $4,007 million in 2022. Diluted earni